Foundry Partners’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-89,419
| Closed | -$5.43M | – | 387 |
|
|
2021
Q2 | $5.43M | Sell |
89,419
-2,271
| -2% | -$138K | 0.19% | 165 |
|
|
2021
Q1 | $6.43M | Sell |
91,690
-3,153
| -3% | -$221K | 0.21% | 147 |
|
|
2020
Q4 | $5.68M | Buy |
94,843
+741
| +0.8% | +$44.3K | 0.22% | 137 |
|
|
2020
Q3 | $5.66M | Sell |
94,102
-1,426
| -1% | -$85.7K | 0.27% | 120 |
|
|
2020
Q2 | $5.01M | Buy |
+95,528
| New | +$5.01M | 0.24% | 133 |
|